In-Human Implantation of a Novel Biologic Valved Conduit for Aortic Root Replacement.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 33839132.
- Also identified by DOI 10.1016/j.athoracsur.2021.03.087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Aortic root replacement is a complex procedure. Recently, the KONECT RESILIA aortic valved conduit (Edwards Lifesciences, Irvine, CA), the first prefabricated biologic valved conduit available in the United States, was approved for use. Here, we report a series of 3 patients representing implantation of the novel Konect AVC. The conduit was implanted in both supraannular and intraannular positions, and the unique design of the sewing ring offers several advantages. The Konect AVC streamlines the process of root replacement and may represent an improvement in terms of ease of implantation and durability.
Medical subject headings
- Aortic Valve
- Bioprosthesis
- Heart Valve Prosthesis
- Heart Valve Prosthesis Implantation